Biodesix, Inc. / Fundamentals
Income statement
- Net revenue
€65.69M - Cost of goods sold
€13.95M - Gross profit
€51.74M - SG&A expenses
€71.29M - R&D expenses
€9.52M - EBITDA
-€25.42M - D&A
€4.83M - EBIT
-€29.25M - Interest expenses
€6.33M - EBT
-€35.24M - Tax expenses
-€1.10M - Net income
-€35.24M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€1.21M - Changes in working capital
-€719.86K - Operating cash flow
-€25.69M - Capex
€1.11M - Other investing cash flow
-€271.99K - Net investing cash flow
-€1.20M - Total cash dividends paid
€0.00 - Issuance of common stock
-€241.96K - Debt repayment
€8.55M - Other financing cash flow
€2.97M - Net financing cash flow
€8.45M - Foreign exchange effects
€0.00 - Net change in cash
-€18.45M - Cash at end of period
€17.86M - Free cash flow
-€24.57M
Balance sheet
- Cash and cash equivalents
€17.78M - Cash and short-term investments
€17.78M - Total receivables
€6.39M - Inventory
€0.00 - Other current assets
€3.66M - Total current assets
€27.84M - Property, plant & equipment
€24.23M - Goodwill
€12.90M - Intangible assets
€4.18M - Long-term investments
€0.00 - Other non-current assets
€6.14M - Total non-current assets
€47.44M - Total assets
€75.28M - Accounts payable
€2.55M - Short-term debt
€1.07M - Other current liabilities
€8.86M - Total current liabilities
€13.01M - Long-term debt
€81.51M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€299.44K - Total non-current liabilities
€61.30M - Total liabilities
€74.30M - Common stock
€125.27K - Retained earnings
-€416.19M - Other equity
€0.00 - Total equity
€976.40K - Total liabilities and shareholders' equity
€75.28M
Company information
- Market capitalization
€31.29M - Employees
273 - Enterprise Value
€91.52M
Company ratios
- Gross margin
-
78.8% Much better than peer group: 24.0% - EBITDA margin
-
-38.7% Much better than peer group: -1,421.6% - EBIT margin
-
-44.5% Much better than peer group: -1,530.6% - EBT margin
-
-53.7% Much better than peer group: -1,515.3% - Net margin
-
-53.7% Much better than peer group: -1,511.1% - ROE
-
-3,609.7% Much worse than peer group: 11.3% - ROA
-
-46.8% Worse than peer group: -29.0% - Asset turnover
-
87.3% Much better than peer group: 53.2% - FCF margin
-
-40.8% Much better than peer group: -1,228.1% - FCF yield
-85.6% - Efficiency ratio
138.7% - Net sales per employee
-
€240.60K - Net income per employee
-
-€129.10K